(Q63811516)
Statements
A Double-Blind, Randomized, Intraindividual, Vehicle-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Topically Applied ATx201 in Subjects With Moderate Atopic Dermatitis (English)
0 references
25 September 2017
0 references
5 March 2018
0 references
31
0 references
18 year
0 references